Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Palliation
What are your preferred dose/fractionation options for treatment of hemoptysis related to central lung metastasis?
Does your management change if the primary tumor is radioresistant, such as renal cell carcinoma?
Answer from: Radiation Oncologist at Community Practice
50 Gy in 5 fractions every other day with SBRT.
Sign in or Register to read more
15235
Related Questions
Do you recommend holding tyrosine-kinase inhibitors for extracranial metastases being treated with SBRT?
How would you manage a patient with a high-risk asymptomatic bone metastasis with a driver mutation?
Would you consider palliative RT in the setting of tumor causing osteonecrosis in an elderly patient?
Do you use a comprehensive volumetric, rather than numeric, cutoff in consideration of SRS vs WBRT for brain metastases?
How do you approach the management of a patient with lumbar spinal metastasis with neurologic symptoms but without evidence of spinal cord compression?
What dose/fractionation scheme would you employ for treatment of a bone with impending fracture prior to surgical fixation?
Do you have a 15 fraction constraint for the LADA?
What is the expected timeframe for the development of radiation myelitis and therapies that have helped with neurologic symptoms?
For bone metastases requiring surgical stabilization, what time interval from the date of surgery do you use for post-op radiation?
How would you manage a cardiac metastasis from Merkel cell carcinoma?